6 Ways Phenotypic Data Improves Decision-Making in Your Drug Development Program

Discover six ways metabolomics provides greater confidence, higher success rates and complements the work of your in-house teams for your drug development pipeline.

While genomics, transcriptomics and proteomics are well-established tools in the drug development arsenal, these tools stop short of providing a definitive representation of the clinical phenotype. Metabolomics can augment the power and utility of these tools by providing an in vivo functional snapshot of all upstream biologic processes, helping you get closer to the phenotype and reveal incremental insights that can increase confidence in your drug development decisions.